PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?

SIMPLE SUMMARY: Prostate cancer still represents an important health problem in men, considering its high frequency. Over the last decade, novel treatment options have emerged, leading to notable clinical benefits. These recent scientific acquisitions are creating the basis to widen the treatment sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Andrea, Rosellini, Matteo, Nuvola, Giacomo, Tassinari, Elisa, Mollica, Veronica, Rizzo, Alessandro, Santoni, Matteo, Cimadamore, Alessia, Farolfi, Andrea, Montironi, Rodolfo, Fanti, Stefano, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869833/
https://www.ncbi.nlm.nih.gov/pubmed/35205654
http://dx.doi.org/10.3390/cancers14040907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869833/
https://www.ncbi.nlm.nih.gov/pubmed/35205654
http://dx.doi.org/10.3390/cancers14040907

Ejemplares similares